Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody

  1. Angela M Phillips  Is a corresponding author
  2. Daniel P Maurer
  3. Caelan Brooks
  4. Thomas Dupic
  5. Aaron G Schmidt
  6. Michael M Desai  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Harvard Medical School, United States
  3. Harvard University, United States

Abstract

Broadly neutralizing antibodies (bnAbs) that neutralize diverse variants of a particular virus are of considerable therapeutic interest1. Recent advances have enabled us to isolate and engineer these antibodies as therapeutics, but eliciting them through vaccination remains challenging, in part due to our limited understanding of how antibodies evolve breadth2. Here, we analyze the landscape by which an anti-influenza receptor binding site (RBS) bnAb, CH65, evolved broad affinity to diverse H1 influenza strains3,4. We do this by generating an antibody library of all possible evolutionary intermediates between the unmutated common ancestor (UCA) and the affinity-matured CH65 antibody and measure the affinity of each intermediate to three distinct H1 antigens. We find that affinity to each antigen requires a specific set of mutations - distributed across the variable light and heavy chains - that interact non-additively (i.e., epistatically). These sets of mutations form a hierarchical pattern across the antigens, with increasingly divergent antigens requiring additional epistatic mutations beyond those required to bind less divergent antigens. We investigate the underlying biochemical and structural basis for these hierarchical sets of epistatic mutations and find that epistasis between heavy chain mutations and a mutation in the light chain at the VH-VL interface is essential for binding a divergent H1. Collectively, this work is the first to comprehensively characterize epistasis between heavy and light chain mutations and shows that such interactions are both strong and widespread. Together with our previous study analyzing a different class of anti-influenza antibodies5, our results implicate epistasis as a general feature of antibody sequence-affinity landscapes that can potentiate and constrain the evolution of breadth.

Data availability

Data and code used for this study are available at https://github.com/amphilli/CH65-comblib. Antibody affinity and expression data are also available in an interactive data browser at https://ch65-ma90-browser.netlify.app/. FASTQ files from high-throughput sequencing are deposited in the NCBI BioProject database under PRJNA886089. X-ray crystal structures of the Fabs reported here are available at the Protein Data Bank (8EK6 and 8EKH).

The following data sets were generated

Article and author information

Author details

  1. Angela M Phillips

    1Department of Organismic and Evolutionary Biology, University of California, San Francisco, San Francisco, United States
    For correspondence
    angela.phillips@ucsf.edu
    Competing interests
    Angela M Phillips, has recently consulted for Leyden Labs..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9806-7574
  2. Daniel P Maurer

    Department of Microbiology, Harvard Medical School, Cambridge, United States
    Competing interests
    No competing interests declared.
  3. Caelan Brooks

    Department of Physics, Harvard University, Cambridge, MA, United States
    Competing interests
    No competing interests declared.
  4. Thomas Dupic

    Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, United States
    Competing interests
    No competing interests declared.
  5. Aaron G Schmidt

    Department of Microbiology, Harvard Medical School, Cambridge, United States
    Competing interests
    No competing interests declared.
  6. Michael M Desai

    Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, United States
    For correspondence
    mdesai@oeb.harvard.edu
    Competing interests
    Michael M Desai, recently consulted for Leyden Labs..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9581-1150

Funding

Howard Hughes Medical Institute (Hanna H. Gray Postdoctoral Fellowship)

  • Angela M Phillips

Human Frontier Science Program (Postdoctoral Fellowship)

  • Thomas Dupic

National Institutes of Health (R01AI146779)

  • Aaron G Schmidt

National Institutes of Health (P01AI89618-A1)

  • Aaron G Schmidt

National Science Foundation (DMS-1764269)

  • Michael M Desai

National Science Foundation (DMS-1655960)

  • Michael M Desai

National Institutes of Health (GM104239)

  • Michael M Desai

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Phillips et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,998
    views
  • 313
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Angela M Phillips
  2. Daniel P Maurer
  3. Caelan Brooks
  4. Thomas Dupic
  5. Aaron G Schmidt
  6. Michael M Desai
(2023)
Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody
eLife 12:e83628.
https://doi.org/10.7554/eLife.83628

Share this article

https://doi.org/10.7554/eLife.83628

Further reading

    1. Computational and Systems Biology
    2. Evolutionary Biology
    Pierre Barrat-Charlaix, Richard A Neher
    Research Article

    As pathogens spread in a population of hosts, immunity is built up, and the pool of susceptible individuals are depleted. This generates selective pressure, to which many human RNA viruses, such as influenza virus or SARS-CoV-2, respond with rapid antigenic evolution and frequent emergence of immune evasive variants. However, the host’s immune systems adapt, and older immune responses wane, such that escape variants only enjoy a growth advantage for a limited time. If variant growth dynamics and reshaping of host-immunity operate on comparable time scales, viral adaptation is determined by eco-evolutionary interactions that are not captured by models of rapid evolution in a fixed environment. Here, we use a Susceptible/Infected model to describe the interaction between an evolving viral population in a dynamic but immunologically diverse host population. We show that depending on strain cross-immunity, heterogeneity of the host population, and durability of immune responses, escape variants initially grow exponentially, but lose their growth advantage before reaching high frequencies. Their subsequent dynamics follows an anomalous random walk determined by future escape variants and results in variant trajectories that are unpredictable. This model can explain the apparent contradiction between the clearly adaptive nature of antigenic evolution and the quasi-neutral dynamics of high-frequency variants observed for influenza viruses.

    1. Ecology
    2. Evolutionary Biology
    Rebecca D Tarvin, Jeffrey L Coleman ... Richard W Fitch
    Research Article

    Understanding the origins of novel, complex phenotypes is a major goal in evolutionary biology. Poison frogs of the family Dendrobatidae have evolved the novel ability to acquire alkaloids from their diet for chemical defense at least three times. However, taxon sampling for alkaloids has been biased towards colorful species, without similar attention paid to inconspicuous ones that are often assumed to be undefended. As a result, our understanding of how chemical defense evolved in this group is incomplete. Here, we provide new data showing that, in contrast to previous studies, species from each undefended poison frog clade have measurable yet low amounts of alkaloids. We confirm that undefended dendrobatids regularly consume mites and ants, which are known sources of alkaloids. Thus, our data suggest that diet is insufficient to explain the defended phenotype. Our data support the existence of a phenotypic intermediate between toxin consumption and sequestration — passive accumulation — that differs from sequestration in that it involves no derived forms of transport and storage mechanisms yet results in low levels of toxin accumulation. We discuss the concept of passive accumulation and its potential role in the origin of chemical defenses in poison frogs and other toxin-sequestering organisms. In light of ideas from pharmacokinetics, we incorporate new and old data from poison frogs into an evolutionary model that could help explain the origins of acquired chemical defenses in animals and provide insight into the molecular processes that govern the fate of ingested toxins.